Custom Health Completes Acquisition of Spencer Health Solutions, Bringing In-Home Medication Dispensing Technology Fully In-House
Effective September 4, 2026, Custom Health has completed its previously announced acquisition of Spencer Health Solutions, developer of the spencer® smart medication dispenser and in-home monitoring platform, giving the Company full ownership of the spencer® technology, intellectual property, and product roadmap. Spencer now operates as a wholly owned subsidiary of Custom Health, eliminating third-party support, infrastructure, and device costs previously incu
Technologies, Pharmaceutique, Santé
2026-09-08 6:00 AM EDT | Custom Health Holdings Inc.
Defence Therapeutics CEO Highlights Recent Progress and Outlines Strategic Priorities in Letter to Shareholders
Montreal, Quebec--(Newsfile Corp. - September 8, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology company developing next-generation precision oncology therapeutics using its proprietary Accum® technology, is pleased to provide a letter to shareholders from President and Chief Executive Officer Dr. Amie Phinney outlining recent corporate progress, strategic priorities and the Company'
Biotechnologies, Pharmaceutique, Santé
2026-09-08 3:15 AM EDT | Defence Therapeutics Inc.
Defence Therapeutics Provides Updates on Sharing Agreement
Montreal, Quebec--(Newsfile Corp. - September 4, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to provide an update on its sharing agreement dated March 6, 2026 (the "Sharing Agreement") with Sorbie Bornholm LP ("SBLP") previously described in the Company's news releases of March 9 and February 27, 202
Biotechnologies, Pharmaceutique, Santé
2026-09-04 6:00 PM EDT | Defence Therapeutics Inc.
First Towers & Fiber Corp. Delivers First Cash Flow from New 200 KM Fiber Network, Eyes Expansion with Client
Toronto, Ontario--(Newsfile Corp. - September 4, 2026) - Akanda Corp. (NASDAQ: AKAN) ("Akanda") and its 100% owned subsidiary First Towers & Fiber Corp. ("FTF" or the "Company"), an emerging telecommunications infrastructure developer in Mexico, today announced a series of operational and financial milestones that mark a significant step forward in the Company's transition into a recurring revenue-generating telecommunications infrastructure business. First Cash Lease Payment Col
Cannabis, Santé, Cultivateurs de cannabis, Producteurs de cannabis
2026-09-04 9:05 AM EDT | Akanda Corp
Edison Issues Report on Percheron Therapeutics (PER)
London, United Kingdom--(Newsfile Corp. - September 4, 2026) - Edison issues report on Percheron Therapeutics (ASX: PER) Percheron's clinical strategy has taken an important turn with the announcement of an investigator-sponsored exploratory study of HMBD-002 in acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS), led by Vanderbilt Health. Percheron's contribution will be limited to providing the study drug, a financial grant and advisory support. Following the announcement
Services bancaires / financiers, Matériel informatique, Logiciels, Santé
2026-09-04 5:00 AM EDT | Edison Group
Tersis Technologies Engages DIFFRNT Developments to Lead Web Development and Digital Infrastructure
Miami, Florida--(Newsfile Corp. - September 3, 2026) - Tersis Technologies, Inc. (OTCID: TERS), a clean technology company advancing waste-to-value and circular infrastructure solutions, today announced that it has engaged DIFFRNT Developments to lead the development, hosting, and ongoing management of the Company's web platforms and digital infrastructure. The engagement brings Tersis's website development, hosting, maintenance, cybersecurity, technical search optimization, CRM integra
Agriculture, Énergie, Énergies de substitution, Santé
2026-09-03 1:01 PM EDT | Tersis Technologies Inc.
AVANT and Health In A Box Launch Physician-Led Preventive Health Programs For Club Members
Toronto, Ontario--(Newsfile Corp. - September 3, 2026) - AVANT, the premium private fitness and wellness club, and Health In A Box® today announced a partnership that brings physician-led preventive health programs to AVANT members beginning in mid-September. Members receive biomarker testing, clinical interpretation, and a personalized health action plan built with a clinical team of physicians and naturopathic doctors. Clinical review and follow-up are delivered virtually. AVANT'
Soins de santé et hôpitaux, Santé
2026-09-03 8:00 AM EDT | Health In A Box Inc.
Rhelion Life Sciences Confirms Further Delivery of Filament Health's PEX010 to Germany's First Psilocybin Compassionate Use Program
Filament Health has completed a further international delivery of its patented, naturally derived psilocybin drug candidate PEX010 to Germany, supporting the first compassionate use program for psilocybin in the European Union The Company believes the continued delivery demonstrates Filament's ability to manufacture, release and supply pharmaceutical-grade botanical psilocybin across international regulatory jurisdictions as new legal access pathways emerge
Cannabis, Santé, Psychédéliques, Fournisseurs de services auxiliaires liés au cannabis
2026-09-03 7:39 AM EDT | Rhelion Life Sciences Corp.
DiagnosTear Technologies Announces FDA Pre-Submission for TeaRx(TM) Red Eye Diagnostic Test
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - DiagnosTear Technologies Inc. (CSE: DTR) (FSE: X8F) ("DiagnosTear" or the "Company"), a developer of innovative point-of-care eye diagnostic solutions, is pleased to announce the submission of a pre-submission request to the U.S. Food and Drug Administration ("FDA") for its TeaRx™ Red Eye diagnostic test (the "Pre-Submission"). The Pre-Submission represents an important regulatory miles
2026-09-03 7:00 AM EDT | DiagnosTear Technologies Inc.
BioHarvest Sciences Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
British Columbia and Rehovot, Israel--(Newsfile Corp. - September 3, 2026) - BioHarvest Sciences Inc. (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development today announced its intention to offer its ordinary shares on the Tel Aviv Stock Exchange (TASE) and to become dual-listed for trade on both the Nasdaq and TASE markets. BioHarvest expects its shares to begin trading on the TASE on September 8, 2026. Dr Zak
Biotechnologies, Pharmaceutique, Santé
2026-09-03 7:00 AM EDT | BioHarvest Sciences Inc.
Restart Life Sciences Reports Second Quarter 2026 Results Highlighted by 146% Sequential Revenue Growth
Vancouver, British Columbia--(Newsfile Corp. - September 3, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce its financial and operating results for the three and six months ended June 30, 2026. All financial figures are expressed in Canadian dollars ($) unless otherwise noted, are prepared in accordance with International Financial Reporting Standards (IFRS), and are unaudited. In the second quarter o
Technologies, Biotechnologies, Santé
2026-09-03 6:00 AM EDT | Restart Life Sciences Corp.
Charlotte's Web Applauds Congressional Action to Advance Continuing Resolution
Louisville, Colorado--(Newsfile Corp. - September 2, 2026) - Charlotte's Web Holdings, Inc. (TSX: CWEB) (OTCQX: CWBHF), the market leader in hemp extract wellness products, today welcomed the U.S. House of Representatives' passage of the continuing resolution (CR), which was approved by a vote of 370-48, following the Senate's earlier passage of the measure. The legislation will now be sent to the President for signature and enactment into law. The passage of the CR helps ensure
2026-09-02 11:07 AM EDT | Charlotte's Web Holdings, Inc.
Hazelden Betty Ford Shares Industry-Leading Recovery Outcomes
Center City, Minnesota--(Newsfile Corp. - September 2, 2026) - The nonprofit Hazelden Betty Ford Foundation, a national leader in substance use and mental health care, today released its annual patient outcomes report from the Butler Center for Research—finding that 70% of patients reported abstinence one year after treatment, 75% achieved recovery-capital levels associated with sustained recovery, and more than 85% reported good overall health and quality of life. The report refl
2026-09-02 9:30 AM EDT | Hazelden Betty Ford Foundation
Apptly Commences Trading on the OTCQB and Becomes DTC Eligible
Vancouver, British Columbia--(Newsfile Corp. - September 2, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (OTCQB: ESVNF) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced that it has been approved to trade on the OTCQB Venture Market ("OTCQB") in the United States under the symbol "ESVNF", effective September 2, 2026. The Company also confirms that its common shares are eligible for electronic clea
2026-09-02 8:00 AM EDT | Apptly Health Technologies Corp.
ONE HEMP Commends House Passage of Continuing Resolution, Reinforcing Path Toward Comprehensive Federal Hemp Regulation
Washington, D.C.--(Newsfile Corp. - September 1, 2026) - ONE HEMP today applauded House passage of the Continuing Resolution which included a four-week extension to enact changes to the Farm Bill's definition of hemp. This action, which was previously approved by the Senate, is a significant step toward Congress developing and enacting a sound federal regulatory framework for hemp-derived products. Once the measure is signed into
2026-09-01 4:40 PM EDT | OneHemp
Tersis Technologies and Flux Core Sign MOU to Advance Decentralized Data Centers and Sustainable AI Compute
Miami, Florida--(Newsfile Corp. - September 1, 2026) - Tersis Technologies, Inc. (OTCID: TERS) ("Tersis" or the "Company"), a clean technology company focused on transforming waste streams into valuable resources, today announced t
Agriculture, Énergie, Énergies de substitution, Santé
2026-09-01 2:33 PM EDT | Tersis Technologies Inc.
Apptly and Koning Announce Strategic Partnership to Expand Patient Access to Non-Compression 3D Breast Imaging
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL) (the "Company" or "Apptly"), operator of the UberDoc direct-pay healthcare marketplace, today announced a strategic partnership with Koning Corporation ("Koning"), manufacturer of the FDA-approved Koning Vera Breast CT. Highlights: FDA-Approved Breast CT: The Koning Vera Breast CT is the o
2026-09-01 8:00 AM EDT | Apptly Health Technologies Corp.
Delota Reports Financial Results for the Three Months Ended June 30, 2026
Highlights: Total revenue of $8.3 million for Q1 2027 Total System-Wide Revenue of $9.9 million for Q1 2027 33% gross profit margin for Q1 2027 Segmented revenue for Q1 2027: Vape - B2C: $4.0 million, B2B: $3.3 million Cannabis - B2C: $1.0 million Launched 180 Smoke Vape Store Express, a co-branded store-with
Commerce de détail, Cannabis, Santé, Dispensaires de cannabis
2026-09-01 7:00 AM EDT | Delota Corp.
TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece
Highlights: LOI with CPO Greece includes exclusive distribution of VIVI Cap™ and VIVI Epi™ throughout Greece, subject to a definitive agreement. Proposed exclusivity is conditional on minimum annual purchase obligations, with combined purchases required to increase by at least 20% year over year to maintain exclusivity. Transfer pricing and the first-year minimum unit commitment will be negotiated an
Technologies, Biotechnologies, Pharmaceutique, Santé
2026-09-01 6:45 AM EDT | TempraMed Technologies Ltd.
Restart Life Sciences Announces Holy Crap's Amazon U.S. Rollout Alongside Next-Generation Protein and Sampling Innovations
Vancouver, British Columbia--(Newsfile Corp. - September 1, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its premium functional food brand, Holy Crap Foods Inc. ("Holy Crap"), has officially launched in the U.S. market through the Amazon USA platform. The initial U.S. rollout features two of the brand's top-performing super seed SKUs alongside a popular variety package. Following a strong ini
Technologies, Biotechnologies, Santé
2026-09-01 6:00 AM EDT | Restart Life Sciences Corp.